Vitamin D: Metabolism

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 2, 2010, Pages 243-253

  Christakos, Sylvia ^a   Ajibade, Dare V ^a   Dhawan, Puneet ^a   Fechner, Adam J ^a   Mady, Leila J ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

FGF23; Kidney; Placenta; Vitamin D binding protein; Vitamin D hydroxylases; Vitamin D metabolites

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; CALCIFEDIOL; CALCITONIN; CALCITRIOL; CALCIUM PHOSPHATE; CYTOCHROME P450; CYTOCHROME P450 27B1; FIBROBLAST GROWTH FACTOR 23; OXYGENASE; PARATHYROID HORMONE; PHOSPHATE; PROLACTIN; STEROID 24 HYDROXYLASE; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

BIOSYNTHESIS; CALCIUM HOMEOSTASIS; CHRONIC KIDNEY DISEASE; HORMONE ACTION; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; HYPOPHOSPHATEMIA; INNATE IMMUNITY; KIDNEY; LACTATION; LIVER; MACROPHAGE; METABOLIC REGULATION; MONOCYTE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RICKETS; SIGNAL TRANSDUCTION; TROPHOBLAST; VITAMIN D DEPENDENT RICKETS TYPE 1; VITAMIN D METABOLISM;

ANIMALS; CHOLECALCIFEROL; CHRONIC DISEASE; CYTOCHROME P-450 CYP27A1; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; LIVER; MACROPHAGES; MICE; PLACENTA; PREGNANCY; STEROID HYDROXYLASES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN;

EID: 77953946274     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.02.002     Document Type: Review

References (73)

1. Webb A.R., Kline L., Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988, 67:373-378.
2. Matsuoka L.Y., Ide L., Wortsman J., et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987, 64:1165-1168.
3. Matsuoka L.Y., Wortsman J., Dannenberg M.J., et al. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab 1992, 75:1099-1103.
4. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004, 29:664-673.
5. Omdahl J.L., Morris H.A., May B.K. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 2002, 22:139-166.
6. Cheng J.B., Levine M.A., Bell N.H., et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 2004, 101:7711-7715.
7. Nykjaer A., Dragun D., Walther D., et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999, 96:507-515.
8. Weisman Y., Harell A., Edelstein S., et al. 1 alpha, 25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979, 281:317-319.
9. Gray T.K., Lester G.E., Lorenc R.S. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy. Science 1979, 204:1311-1313.
10. Stoffels K., Overbergh L., Bouillon R., et al. Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway. J Steroid Biochem Mol Biol 2007, 103:567-571.
11. Esteban L., Vidal M., Dusso A. 1alpha-Hydroxylase transactivation by gamma-interferon in murine macrophages requires enhanced C/EBPbeta expression and activation. J Steroid Biochem Mol Biol 2004, 89-90:131-137.
12. Kitanaka S., Takeyama K., Murayama A., et al. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998, 338:653-661.
13. Panda D.K., Miao D., Tremblay M.L., et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 2001, 98:7498-7503.
14. Dardenne O., Prud'homme J., Arabian A., et al. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
15. Safadi F.F., Thornton P., Magiera H., et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999, 103:239-251.
16. Bikle D.D., Siiteri P.K., Ryzen E., et al. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 1985, 61:969-975.
17. Zella L.A., Shevde N.K., Hollis B.W., et al. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008, 149:3656-3667.
18. Shinki T., Jin C.H., Nishimura A., et al. Parathyroid hormone inhibits 25-hydroxyvitamin D3-24-hydroxylase mRNA expression stimulated by 1 alpha,25-dihydroxyvitamin D3 in rat kidney but not in intestine. J Biol Chem 1992, 267:13757-13762.
19. St-Arnaud R., Arabian A., Travers R., et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000, 141:2658-2666.
20. Henry H.L., Norman A.W. Vitamin D: metabolism and biological actions. Annu Rev Nutr 1984, 4:493-520.
21. DeLuca H.F. Evolution of our understanding of vitamin D. Nutr Rev 2008, 66:S73-S87.
22. Boyle I.T., Gray R.W., DeLuca H.F. Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol. Proc Natl Acad Sci U S A 1971, 68:2131-2134.
23. Henry H.L. Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin. Endocrinology 1985, 116:503-510.
24. Murayama A., Takeyama K., Kitanaka S., et al. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology 1999, 140:2224-2231.
25. Brenza H.L., Kimmel-Jehan C., Jehan F., et al. Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc Natl Acad Sci U S A 1998, 95:1387-1391.
26. Zierold C., Nehring J.A., DeLuca H.F. Nuclear receptor 4A2 and C/EBPbeta regulate the parathyroid hormone-mediated transcriptional regulation of the 25-hydroxyvitamin D3-1alpha-hydroxylase. Arch Biochem Biophys 2007, 460:233-239.
27. Murayama A., Takeyama K., Kitanaka S., et al. The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. Biochem Biophys Res Commun 1998, 249:11-16.
28. Kim M.S., Fujiki R., Murayama A., et al. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol 2007, 21:334-342.
29. Brenza H.L., DeLuca H.F. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. Arch Biochem Biophys 2000, 381:143-152.
30. Murayama A., Kim M.S., Yanagisawa J., et al. 2004 Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J 2000, 23:1598-1608.
31. Dhawan P., Peng X., Sutton A.L., et al. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol Cell Biol 2005, 25:472-487.
32. Christakos S., Dhawan P., Shen Q., et al. New insights into the mechanisms involved in the pleiotropic actions of 1,25dihydroxyvitamin D3. Ann N Y Acad Sci 2006, 1068:194-203.
33. Zhong Y., Christakos S. 2006 Novel mechanism of vitamin D receptor (VDR) activation: histone H3 lysine 9 methyltransferase is a transcriptional coactivator for VDR. J Bone Miner Res 2007, 22(Suppl 1):S8.
34. Bai X., Miao D., Li J., et al. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 2004, 145:5269-5279.
35. Goetz R., Beenken A., Ibrahimi O.A., et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 2007, 27:3417-3428.
36. ADHR Consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000, 26:345-348.
37. Shimada T., Mizutani S., Muto T., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001, 98:6500-6505.
38. White K.E., Carn G., Lorenz-Depiereux B., et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 2001, 60:2079-2086.
39. Weber T.J., Liu S., Indridason O.S., et al. Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 2003, 18:1227-1234.
40. Liu S., Tang W., Zhou J., et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006, 17:1305-1315.
41. Shimada T., Kakitani M., Yamazaki Y., et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004, 113:561-568.
42. Kurosu H., Ogawa Y., Miyoshi M., et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 2006, 281:6120-6123.
43. Imura A., Tsuji Y., Murata M., et al. Alpha-Klotho as a regulator of calcium homeostasis. Science 2007, 316:1615-1618.
44. Kuro-o M., Matsumura Y., Aizawa H., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390:45-51.
45. Tsujikawa H., Kurotaki Y., Fujimori T., et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003, 17:2393-2403.
46. Urakawa I., Yamazaki Y., Shimada T., et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006, 444:770-774.
47. Yoshida T., Fujimori T., Nabeshima Y. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 2002, 143:683.
48. Pike J.W., Spanos E., Colston K.W., et al. Influence of estrogen on renal vitamin D hydroxylases and serum 1alpha,25-(OH)2D3 in chicks. Am J Physiol 1978, 235:E338-E343.
49. Tanaka Y., Castillo L., Wineland M.J., et al. Synergistic effect of progesterone, testosterone, and estradiol in the stimulation of chick renal 25-hydroxyvitamin D3-1alpha-hydroxylase. Endocrinology 1978, 103:2035-2039.
50. Baksi S.N., Kenny A.D. Does estradiol stimulate in vivo production of 1,25-dihydroxyvitamin D3 in the rat?. Life Sci 1978, 22:787-792.
51. Shinki T., Ueno Y., DeLuca H.F., et al. Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats. Proc Natl Acad Sci U S A 1999, 96:8253-8258.
52. Kawashima H., Torikai S., Kurokawa K. Calcitonin selectively stimulates 25-hydroxyvitamin D3-1 alpha-hydroxylase in proximal straight tubule of rat kidney. Nature 1981, 291:327-329.
53. Galante L., Colston K.W., MacAuley S.J., et al. Effect of calcitonin on vitamin D metabolism. Nature 1972, 238:271-273.
54. Stevenson J.C., Hillyard C.J., MacIntyre I., et al. A physiological role for calcitonin: protection of the maternal skeleton. Lancet 1979, 2:769-770.
55. Kumar R., Cohen W.R., Silva P., et al. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest 1979, 63:342-344.
56. Zhong Y., Armbrecht H.J., Christakos S. Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene. J Biol Chem 2009, 284:11059-11069.
57. Robinson C.J., Spanos E., James M.F., et al. Role of prolactin in vitamin D metabolism and calcium absorption during lactation in the rat. J Endocrinol 1982, 94:443-453.
58. Ajibade DV, Dhawan P, Christakos S. Prolactin: a regulator of the 25-hydroxyvitaminD3 1alpha hydroxylase gene. J Bone Miner Res 2009;24(Suppl 1). Available at: Accessed September 17, 2009. http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=51d4e88b-f79d-47e2-a15b-134f0c57b52.e.
59. Cundy T., Haining S.A., Guilland-Cumming D.F., et al. Remission of hypoparathyroidism during lactation: evidence for a physiological role for prolactin in the regulation of vitamin D metabolism. Clin Endocrinol (Oxf) 1987, 26:667-674.
60. Caplan R.H., Beguin E.A. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstet Gynecol 1990, 76:485-489.
61. Zehnder D., Evans K.N., Kilby M.D., et al. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol 2002, 161:105-114.
62. Evans K.N., Nguyen L., Chan J., et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 2006, 75:816-822.
63. Liu N., Kaplan A.T., Low J., et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod 2009, 80:398-406.
64. Novakovic B., Sibson M., Ng H.K., et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009, 284:14838-14848.
65. Sharma O.P. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000, 6:442-447.
66. Armbrecht H.J., Zenser T.V., Davis B.B. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat. J Clin Invest 1980, 66:1118-1123.
67. Matkovits T., Christakos S. Variable in vivo regulation of rat vitamin D-dependent genes (osteopontin, Ca, Mg-adenosine triphosphatase, and 25-hydroxyvitamin D3 24-hydroxylase): implications for differing mechanisms of regulation and involvement of multiple factors. Endocrinology 1995, 136:3971-3982.
68. Tsai K.S., Heath H., Kumar R., et al. Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. J Clin Invest 1984, 73:1668-1672.
69. Cheng S., Coyne D. Vitamin D and outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 2007, 16:77-82.
70. Lee S.W., Russell J., Avioli L.V. 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. Science 1977, 195:994-996.
71. Portale A.A., Booth B.E., Halloran B.P., et al. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984, 73:1580-1589.
72. Hsu C.H., Vanholder R., Patel S., et al. Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism. Kidney Int 1991, 40:868-873.
73. Gutierrez O., Isakova T., Rhee E., et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005, 16:2205-2215.